IL1B and arthritic joint disease: It is evident that the first phase of arthritis is accompanied with the release of mediators such as histamine and proinflammatory cytokines, particularly TNF-α and IL-1β (Vaghef-Mehrabany et al., 2014; Zaringhalam et al., 2016).